Listed

Cooper Companies, Inc.: Form 10-Q for the period ended Jul 31, 2026

Filed with the SEC on Sep 9, 2026 and accepted by EDGAR at Sep 9, 2026, 16:48 ET.

Share

Management's discussion and analysis

As filed, 1,193 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In September 2025, the authorization under the 2012 Share Repurchase Program was increased to $2.0 billion by the Company's Board of Directors. As of July 31, 2026, $521.7 million remains authorized for repurchase.

In September 2026, the Company's Board of Directors approved an increase of $1.0 billion under the Company's 2012 Share Repurchase Program, increasing the total authorization to $3.0 billion. As of the date of approval, approximately $1.5 billion remains authorized for repurchase.

The following table provides information about the shares repurchased by the Company for the three months ended July 31, 2026:

Period Total number of shares purchased (in thousands) Average price paid per share Total number of shares purchased as part of publicly announced plan (in thousands) Approximate dollar value of shares that may yet be purchased under the plan (in millions)
May 1, 2026 to May 31, 2026 — $— — $860.8
June 1, 2026 to June 30, 2026 3,412.8 67.79 3,412.8 629.4
July 1, 2026 to July 31, 2026 1,489.3 72.30 1,489.3 521.7
Total 4,902.1 $69.16 4,902.1 $521.7

Market risk

As filed, 2,449 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risks that relate principally to changes in interest rates and foreign currency fluctuations. We do not enter into derivative financial instrument transactions for speculative purposes.

Foreign Currency Exchange Risk

We operate multiple foreign subsidiaries that manufacture and market our products worldwide. As a result, our earnings, cash flow and financial position are exposed to foreign currency risk from foreign currency denominated receivables and payables, sales transactions, capital expenditures and net investment in certain foreign operations. Most of our operations outside the United States have their local currency as their functional currency. We have exposure to multiple foreign currencies, including, among others, the British pound, Euro and Japanese yen. We have taken steps to minimize our balance sheet exposure by entering into foreign currency forward contracts to minimize the short-term impact of foreign currency exchange rate fluctuations on certain trade and intercompany receivables and payables.

At July 31, 2026, a uniform hypothetical 10% increase or decrease in the foreign currency exchange rates in comparison to the value of the U.S. dollar would have resulted in a corresponding increase or decrease of approximately $29.5 million in operating income for the fiscal quarter ended July 31, 2026. See Note 11. Financial Derivatives and Hedging of the Consolidated Condensed Financial Statements for further information.

Interest Rate Risk

We are exposed to risks associated with changes in interest rates. Net of interest rate swaps, the majority of our total indebtedness remains subject to US-based variable interest rate risk tied to changes in the federal funds rate and SOFR. We have entered, and in the future may enter, into interest rate swaps to manage interest rate risk.

Our ultimate realized gain or loss with respect to interest rate fluctuations will depend on interest rates, the exposures that arise during the period and our hedging strategies at that time. As an example, if interest rates were to increase or decrease by 1% or 100 basis points, the quarterly interest expense would not have a material impact, based on average debt outstanding, after consideration of our interest rate swap contracts, during the third quarter of fiscal 2026. See Note 4. Financing Arrangements of the Consolidated Condensed Financial Statements for further information.

Controls and procedures

As filed, 1,427 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Based on management’s evaluation (with the participation of our Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer)), as of the end of the period covered by this report, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the Exchange Act)) are effective as of July 31, 2026 to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act during our third quarter of fiscal 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 818 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our business faces significant risks. These risks include those referenced below and may include additional risks and uncertainties not presently known to us or that we currently deem immaterial. Our business, financial condition and results of operations could be materially adversely affected by any of these risks, and the trading prices of our common stock could decline by virtue of these risks. These risks should be read in conjunction with the other information in this report.

Risk factors describing the major risks to our business can be found under Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended October 31, 2025. There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2025.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-07-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2026-05-01 to 2026-07-31$1.07bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2025-11-01 to 2026-07-31$3.17bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2026-05-01 to 2026-07-31$354.3mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2025-11-01 to 2026-07-31$1.03bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2026-05-01 to 2026-07-31$711.9mus-gaap:GrossProfit
Gross profit9 months2025-11-01 to 2026-07-31$2.14bnus-gaap:GrossProfit
Research and development3 months2026-05-01 to 2026-07-31$41.6mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2025-11-01 to 2026-07-31$128.4mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2026-05-01 to 2026-07-31$401.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2025-11-01 to 2026-07-31$1.47bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2026-05-01 to 2026-07-31$222.0mus-gaap:OperatingIncomeLoss
Operating income9 months2025-11-01 to 2026-07-31$403.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2026-05-01 to 2026-07-31$21.5mus-gaap:InterestExpenseNonoperating
Interest expense9 months2025-11-01 to 2026-07-31$64.8mus-gaap:InterestExpenseNonoperating
Income tax3 months2026-05-01 to 2026-07-31−$231.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2025-11-01 to 2026-07-31−$140.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2026-05-01 to 2026-07-31$432.8mus-gaap:NetIncomeLoss
Net income9 months2025-11-01 to 2026-07-31$485.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2026-05-01 to 2026-07-31$2.24us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2025-11-01 to 2026-07-31$2.49us-gaap:EarningsPerShareDiluted
Basic EPS3 months2026-05-01 to 2026-07-31$2.24us-gaap:EarningsPerShareBasic
Basic EPS9 months2025-11-01 to 2026-07-31$2.50us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2026-05-01 to 2026-07-31193,400,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2025-11-01 to 2026-07-31195,200,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2025-11-01 to 2026-07-31$785.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2025-11-01 to 2026-07-31$257.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2025-11-01 to 2026-07-31$447.2mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2026-07-31$154.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2026-07-31$2.28bnus-gaap:AssetsCurrent
Total assetsAt period end2026-07-31$12.67bnus-gaap:Assets
Current liabilitiesAt period end2026-07-31$1.87bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2026-07-31$4.34bnus-gaap:Liabilities
Long-term debtAt period end2026-07-31$1.91bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2026-07-31$628.1mus-gaap:DebtCurrent
Short-term borrowingsAt period end2026-07-31$627.5mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2026-07-31$8.33bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-26-061160. Last ingested by Listed: Oct 27, 2026, 16:37 ET. Listed shows no prices and gives no investment advice.